The recently announced decision by United Healthcare to select Medtronic as the preferred provider of insulin pumps limits the choice of people living with diabetes, and reduces access to therapies and tools that benefit them. While we are still endeavoring to learn all implications of the arrangement, JDRF is deeply troubled by this decision, and we strongly urge United Healthcare and Medtronic to reconsider it.